Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Resistance, Neoplasm | 13 | 2023 | 5336 | 0.760 |
Why?
|
Polymerase Chain Reaction | 3 | 2024 | 6085 | 0.480 |
Why?
|
Lung Neoplasms | 11 | 2024 | 13576 | 0.380 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2024 | 5422 | 0.370 |
Why?
|
DNA, Neoplasm | 5 | 2020 | 1748 | 0.370 |
Why?
|
DNA Mutational Analysis | 5 | 2024 | 4120 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 7 | 2021 | 5708 | 0.210 |
Why?
|
Mutation | 14 | 2024 | 30228 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2024 | 3666 | 0.150 |
Why?
|
Facial Transplantation | 1 | 2020 | 222 | 0.140 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2020 | 354 | 0.140 |
Why?
|
Arm | 1 | 2020 | 590 | 0.140 |
Why?
|
Poisson Distribution | 1 | 2018 | 509 | 0.130 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 146 | 0.130 |
Why?
|
Thiophenes | 1 | 2020 | 569 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 566 | 0.130 |
Why?
|
Janus Kinase 2 | 2 | 2018 | 560 | 0.130 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2046 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2019 | 2433 | 0.120 |
Why?
|
Interferons | 1 | 2018 | 716 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1766 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2019 | 617 | 0.110 |
Why?
|
Acrylamides | 1 | 2015 | 260 | 0.110 |
Why?
|
Specimen Handling | 1 | 2018 | 708 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13697 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2019 | 1277 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 567 | 0.100 |
Why?
|
Pyrimidines | 2 | 2023 | 3048 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1643 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 737 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 959 | 0.100 |
Why?
|
Sulfonamides | 1 | 2020 | 1980 | 0.090 |
Why?
|
Alleles | 2 | 2020 | 6892 | 0.090 |
Why?
|
Aniline Compounds | 1 | 2015 | 1094 | 0.080 |
Why?
|
Quinazolines | 3 | 2015 | 1373 | 0.080 |
Why?
|
Cytological Techniques | 1 | 2011 | 218 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2247 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2058 | 0.080 |
Why?
|
Genotype | 3 | 2018 | 13042 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2952 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3675 | 0.070 |
Why?
|
Graft Rejection | 1 | 2020 | 4505 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3078 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2884 | 0.060 |
Why?
|
Exons | 3 | 2024 | 2392 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6971 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6006 | 0.060 |
Why?
|
Deoxyribonuclease I | 1 | 2006 | 225 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3620 | 0.060 |
Why?
|
Thrombocythemia, Essential | 1 | 2006 | 114 | 0.060 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 17135 | 0.060 |
Why?
|
Polycythemia Vera | 1 | 2006 | 160 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2011 | 957 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2015 | 2533 | 0.060 |
Why?
|
Pyridines | 3 | 2020 | 2889 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2024 | 65379 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1742 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2017 | 755 | 0.050 |
Why?
|
Humans | 23 | 2024 | 768393 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11854 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4526 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9433 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3587 | 0.040 |
Why?
|
Point Mutation | 1 | 2006 | 1594 | 0.040 |
Why?
|
DNA | 1 | 2014 | 7211 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 287 | 0.040 |
Why?
|
Gene Amplification | 1 | 2024 | 1090 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6406 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21162 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8634 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2020 | 877 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 2524 | 0.030 |
Why?
|
Mice | 5 | 2024 | 82017 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1409 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1671 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 673 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 530 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1762 | 0.030 |
Why?
|
Smad Proteins | 1 | 2015 | 157 | 0.030 |
Why?
|
Female | 11 | 2024 | 397089 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 306 | 0.030 |
Why?
|
Animals | 6 | 2024 | 169337 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 414 | 0.030 |
Why?
|
Cell-Free System | 1 | 2014 | 340 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2588 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10478 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1736 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 968 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3632 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 637 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 906 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4142 | 0.020 |
Why?
|
HT29 Cells | 1 | 2011 | 190 | 0.020 |
Why?
|
Plasma | 1 | 2014 | 585 | 0.020 |
Why?
|
Filtration | 1 | 2011 | 228 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2389 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1642 | 0.020 |
Why?
|
Male | 7 | 2024 | 364902 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2552 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22385 | 0.020 |
Why?
|
Cell Size | 1 | 2011 | 626 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1536 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2728 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1975 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5151 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3623 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2968 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1726 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23631 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2006 | 306 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9516 | 0.010 |
Why?
|
Middle Aged | 4 | 2024 | 223491 | 0.010 |
Why?
|
Formaldehyde | 1 | 2006 | 361 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9493 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4588 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2673 | 0.010 |
Why?
|
Aged | 3 | 2024 | 171562 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1539 | 0.010 |
Why?
|
Adult | 3 | 2024 | 223640 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11254 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9510 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59686 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16721 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11120 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54920 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14737 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15455 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_